Japan's Olympus to sell microscope unit to Bain for $3 billion
Reuters
Published Aug 29, 2022 02:28AM ET
Updated Aug 29, 2022 10:16AM ET
By Makiko Yamazaki
TOKYO (Reuters) -Olympus Corp said on Monday it had agreed to sell its microscope unit to private equity firm Bain Capital for 427.6 billion yen ($3.1 billion), in what would be the Japanese company's biggest divestment yet.
The sale of the unit, which also makes industrial endoscopes and x-ray analysers, comes as Olympus speeds the overhaul of its business portfolio, so as to focus solely on medical technology.
The unit is to be transferred to Bain on Jan. 4 next year, subject to antitrust regulatory approvals in Japan and abroad.
In a statement, Olympus said the transfer to Bain would be in its best interest to allow the business to grow with more agile and flexible decision-making based on market needs.
Bain won over global private equity firms such as Carlyle Group (NASDAQ:CG) and KKR & Co (NYSE:KKR), people with direct knowledge have said.
Private equity has been targeting Japan, the world's third-largest economy, where conglomerates have been hiving off non-core assets.
Bain owns flash memory chip maker Kioxia Holdings Corp and is proceeding to a second bidding round for Toshiba (OTC:TOSYY) Corp.
In its overhaul, Olympus has invited activist investor ValueAct Capital on to its board, bought several overseas medical equipment firms and sold its digital camera business that had been a longtime money-loser.
Its shares have nearly tripled since it started to re-organise itself early in 2019.
Olympus, which began more than a century ago as a domestic maker of microscopes, spun off the unit in April for a potential sale even though it was profitable.
With assets of 165 billion yen by the end of June, the unit has forecast operating profit of 26.5 billion yen for the current financial year.
($1=138.7400 yen)
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.